Patent details

Basic Information

Publication number:

EP0879056

PCT Application Number:

PCT/US/97/00600

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP979047651

PCT Publication Number:

WO/97/26883

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODULATION OF TH1/TH2 CYTOKINE EXPRESSION BY RIBAVIRIN IN ACTIVATED T-LYMPHOCYTES

French Title of Invention:

MODULATION DE L'EXPRESSION DE LA CYTOKINE DE TH1/TH2 PAR LA RIBAVIRINE DANS LES LYMPHOCYTES T ACTIVES

German Title of Invention:

MODULATION DER TH1/TH2 CYTOKINEXPRESSION DURCH RIBAVIRIN IN AKTIVIERTEN T-LYMPHOZYTEN

SPC Number:

Dates

Filing date:

21/01/1997

Grant date:

02/05/2002

EP Publication Date:

02/05/2002

PCT Publication Date:

31/07/1997

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/11/1998

EP B1 Publication Date:

02/05/2002

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

21/01/2017

Renunciation date:

Revocation date:

21/01/2008

Annulment date:

Owner

From:

05/09/2002

 

 

Name:

Ribapharm Inc.

Address:

3300 Hyland Avenue, Costa Mesa, CA 92626, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

08/05/2002

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

AVERETT Devron

Address:

United States (US)

2

Name:

RAMASAMY Kandsamy

Address:

United States (US)

3

Name:

TAM Robert

Address:

United States (US)

Priority

1

Priority Number:

590449

Priority Date:

23/01/1996

Priority Country:

United States (US)

2

Priority Number:

36094 P

Priority Date:

17/01/1997

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/52;

Filing date	Document type	Number of pages